Sort
50,496 grants matching “lung cancer”
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$1,071,030Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
$1,070,836Samuel E. Adunyah · Meharry Medical College · U54 · FY2014 · CA
Novel bi-specific immunoprophylactics against multi-drug resistant Gram-negative bacterial infections
$1,070,621David S Perlin · Hackensack University Medical Center · R01 · FY2019 · AI
Multiscale Mathematical Modeling of Cancer Progression
$1,070,597Vito Quaranta · Vanderbilt University · U54 · FY2012 · CA
Multi-Center Study of Pancreatic Cancer Etiology
$1,070,318Margaret T Mandelson · Kaiser Foundation Health Plan Of Washington · R01 · FY2008 · CA
Targeting DNA damage response pathways for the treatment of advanced lung cancer
$1,070,134Diane S Keeney · Cumberland Pharmaceuticals, Inc. · R44 · FY2019 · CA
RESTORATION OF APOPTOSIS IN CANCER
$1,070,099University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Bioinformatics
$1,069,886Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,069,555Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Family Risk and Lung Cancer Study
$1,069,256Colleen M Mc Bride · National Human Genome Research Institute · Z01 · FY2008 · HG
Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial
$1,068,862William Lake · Information Management Services, Inc. · N02 · FY2012 · CA
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,068,291New York University School Of Medicine · U01 · FY2000 · CA
Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery
$1,068,000Matthew L Meyerson · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Duke Cancer Health Disparities P20 SPORE
$1,067,994Steven R Patierno · Duke University · P20 · FY2021 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,067,511Trever G Bivona · University Of California, San Francisco · U54 · FY2023 · CA
Informatics Tools for Optimized Imaging Biomarkers for Cancer Research&Discovery
$1,067,437Bruce R Rosen · Massachusetts General Hospital · U24 · FY2015 · CA
Repository Services for epidemiology studies
$1,066,827Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
Red Cell Biology
$1,066,618David M. Bodine · National Human Genome Research Institute · ZIA · FY2022 · HG
Role of IKK alpha in lung cancer development
$1,066,264Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
UGI Cancer Genetic Studies
$1,066,237Philip Taylor · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
PROSTATE, LUNG, COLORECTAL, &OVARIAN CANCER SCREENING
$1,065,725Westat, Inc. · N01 · FY2000 · CN
Detroit Research on Cancer Survivors (Detroit ROCS)
$1,065,093Ann G Schwartz · Wayne State University · U01 · FY2025 · CA
Profiling cancer neoantigen repertoires and validating immunotherapy targets
$1,064,486Martin W McIntosh · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
$1,064,328Steven M Kawut · University Of Pennsylvania · R01 · FY2021 · HL
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
$1,063,219Michael J Thun · American Cancer Society, Inc. · U01 · FY2008 · CA